EM5-26052-99369
3 vaccinations
6 coded responses
28 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 551 / MN
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-05
Registered in v-safe
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-17
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
- 2021-04-24
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
-
2021-05-21
Survey response — day 28, dose 2MedDRA: Blindness, Migraine — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Silent migraines with vision lossMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-28
- 2021-06-04
-
2021-07-23
Survey response — 3 months, dose 2MedDRA: Cough, Eye irritation, Neuralgia, Oropharyngeal pain, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throat, sneezing, cough, burning eyes, nerve painMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-23
Survey response — 6 months, dose 2MedDRA: Gastrointestinal disorder, Ophthalmic migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: Ocular migraines. And stomach issues that have yet to be diagnosed. NMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Dose 3 — Pfizer-BioNTech
- 2021-12-28
-
2022-01-03
Survey response — day 14, dose 3MedDRA: Tachycardia — Feeling: GoodFree text: Increased tachycardiaMedDRA releases: 2024-11 · check-in free text available
- 2022-01-10
- 2022-01-17
- 2022-01-24
- 2022-01-31
- 2022-03-21
-
2022-06-21
Survey response — 6 months, dose 3MedDRA: Alopecia, Migraine, SARS-CoV-2 test positive, Skin ulcer, Vision blurred, Vitreous floaters — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Covid in May that I continually tested positive for for 13 days. Eye floaters increase, blurred vision, a29 day migraine, skin sores, hair lossMedDRA releases: 2024-11 · check-in free text available
-
2022-12-24
Survey response — 12 months, dose 3MedDRA: Rash, Vision blurred, Visual impairment, Vitreous floaters — Feeling: FairFree text: Rashes that come and go. Really bad eye floaters that block - hamper my vision. Blurry vision that comes and goes.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-12-20 | Pfizer-BioNTech | No |
Free text
Release 8 — day 28, dose 2
Symptoms: Silent migraines with vision loss
Release 9 — 3 months, dose 2
Symptoms: Sore throat, sneezing, cough, burning eyes, nerve pain
Release 10 — 6 months, dose 2
Symptoms: Ocular migraines. And stomach issues that have yet to be diagnosed. N
Release 10 — day 14, dose 3
Symptoms: Increased tachycardia
Release 12 — 6 months, dose 3
Symptoms: Covid in May that I continually tested positive for for 13 days. Eye floaters increase, blurred vision, a29 day migraine, skin sores, hair loss
Release 12 — 12 months, dose 3
Symptoms: Rashes that come and go. Really bad eye floaters that block - hamper my vision. Blurry vision that comes and goes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Blindness | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Eye irritation | ✓ | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Neuralgia | ✓ | · | ✓ |
| SD | Ophthalmic migraine | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Skin ulcer | · | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release